Načítá se...
B Cell Therapy for Multiple Sclerosis: Entering an Era
Monoclonal antibodies that target CD20 expressing B cells represent an important new treatment option for patients with multiple sclerosis (MS). B cell depleting therapy is highly effective against relapsing forms of the disease, and is also the first treatment approach proven to protect against dis...
Uloženo v:
| Vydáno v: | Ann Neurol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876115/ https://ncbi.nlm.nih.gov/pubmed/29244240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25119 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|